Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

Open Access

Peer-reviewed

Research Article

Yingbo Shao,

Affiliations Department of Breast oncology, The Affiliated Cancer Hospital Of Zhengzhou University, Zhengzhou, China, He’nan Province Tumor Hospital, Zhengzhou, China
⨯
Xianfu Sun,

Affiliations Department of Breast oncology, The Affiliated Cancer Hospital Of Zhengzhou University, Zhengzhou, China, He’nan Province Tumor Hospital, Zhengzhou, China
⨯
Yaning He,

Affiliations Department of Breast oncology, The Affiliated Cancer Hospital Of Zhengzhou University, Zhengzhou, China, He’nan Province Tumor Hospital, Zhengzhou, China
⨯
Chaojun Liu,

Affiliations Department of Breast oncology, The Affiliated Cancer Hospital Of Zhengzhou University, Zhengzhou, China, He’nan Province Tumor Hospital, Zhengzhou, China
⨯
Hui Liu

* E-mail: liuhuimed@126.com

Affiliations Department of Breast oncology, The Affiliated Cancer Hospital Of Zhengzhou University, Zhengzhou, China, He’nan Province Tumor Hospital, Zhengzhou, China
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Surgical oncology
Is the Subject Area "Surgical oncology" applicable to this article?

Thanks for your feedback.
Surgical and invasive medical procedures
Is the Subject Area "Surgical and invasive medical procedures" applicable to this article?

Thanks for your feedback.
Epidermal growth factor
Is the Subject Area "Epidermal growth factor" applicable to this article?

Thanks for your feedback.
Regression analysis
Is the Subject Area "Regression analysis" applicable to this article?

Thanks for your feedback.